Resting-state MEG measurement of functional activation as a biomarker for cognitive decline in MS
Deborah N. Schoonhoven(Amsterdam University Medical Centers), Eva Strijbis(Amsterdam University Medical Centers), Bernard M.J. Uitdehaag(Amsterdam UMC Location Vrije Universiteit Amsterdam), Arjan Hillebrand(Amsterdam UMC Location Vrije Universiteit Amsterdam), Jeroen J.G. Geurts(Amsterdam Neuroscience), Prejaas Tewarie(University of Nottingham), A. J. C. Eijlers(Amsterdam Neuroscience), Matteo Fraschini(University of Cagliari), Menno M. Schoonheim(Amsterdam Neuroscience), Cornelis J. Stam(Amsterdam Neuroscience)
Cited by 32
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k
Multiple sclerosis
|The Lancet|2018|1.8k
Reduced resting-state brain activity in the “default network” in normal aging
|Cerebral Cortex|2007|1.2k